Human clone experiment repeated successfully
WASHINGTON (Reuters) -- The only researchers to publicly show that
they have cloned a human embryo said on Tuesday that they had
successfully repeated the experiment, growing an embryo to the
16-cell stage.
 |
|
HEALTH LIBRARY |
| |
|
|
YOUR E-MAIL
ALERTS |
Follow the news that matters to
you. Create
your own alert to be notified on topics you're
interested in. Or, visit Popular
Alerts for suggestions.
| |
Researchers at Advanced Cell Technology of Worcester,
Massachusetts, have also repeatedly created embryos using a process
called parthenogenesis -- using only a human egg cell and no sperm,
and without cloning.
The company says the experiments, reported in the January issue
of Wired magazine, are not breakthroughs but a natural progression
of its efforts to create human embryonic stem cells to use for
medical treatments.
"It's not a scientific advance," ACT medical director Dr. Robert
Lanza said in a telephone interview.
But he said the researchers had managed to replicate experiments
reported in late 2001, in which they used cloning technology to
create a human embryo that grew to the six-cell stage. They also
created more advanced embryos, called blastocysts, using
parthenogenesis.
Sheep, cattle and pigs have all been cloned using an egg cell and
an adult cell from another animal.
But critics had questioned whether the cloning process known as
nuclear transfer has ever worked with humans. Lanza said the new
experiments, which began last June, suggest they were successful.
A 'virgin birth'
Even more successful were the parthenogenesis experiments -- in
which five of eight human eggs were coaxed into growing into
blastocysts. At this stage -- approximately 100 cells -- an embryo
can be mined for its stem cells.
The stem cells -- nature's template for all cells -- can become
any sort of cell or tissue in the body.
Scientists hope the cells may one day allow custom-made tissue
transplants to heal damaged hearts or cure diabetes by replacing
dead pancreatic cells.
Opponents raise moral objections, saying that cloning technology
involved in making embryonic stem cells creates a living human
being.
The U.S. federal government refuses to fund embryonic stem cell
research beyond a few limited cultures, while Congress and some
members of the United Nations have made several failed attempts to
ban so-called therapeutic cloning outright.
Lanza says parthenogenesis can bypass these objections.
Parthenogenesis is not known to lead to the development of a fetus
in mammals.
"If implanted into a woman's uterus, we don't think it would
develop into a child," he said.
But the resulting blastocyst, called a parthenote, can be a
source of embryonic stem cells. Tissue from such cells would be
easier to match with patients and less likely to be rejected, Lanza
said, because they contain only one person's DNA.
It also would be more readily available than tissue from a
patient's cloned cells, which would take months to prepare.
"For many therapies you don't have time to start from scratch,"
he said.
It would take just 40 batches, or lines, of parthenote-generated
stem cells to create tissue matches for 70 percent of the U.S.
public, Lanza said. Embryonic stem cells are immortal, so it would
not take many human eggs to create several dozen lines.
Copyright 2003
Reuters. All rights
reserved. This material may not be published, broadcast, rewritten,
or redistributed.
